Search

Search results

1. The Misguided War against Medicines 2011

   Government spending on all types of prescription drugs (patented and non-patented) is increasing faster than any other component of health spending. And new or patented medicines tend to be more expensive compared to older drugs and other health ...

2. Canada's Drug Price Paradox, 2010

   Since 2005, this study has regulary compared Canadian and American retail prices for an identical group of the 100 most commonly prescribed brand-name (mostly patented) drugs and the 100 most commonly prescribed generic drugs in Canada. This year?s study ...

3. The Misguided War Against Medicines 2010

   The Misguided War against Medicines 2010 examines all of the ways in which spending on drugs may contribute to the overall growth in total government health spending. The evidence suggests that neither patented medicines in particular, nor prescription ...

4. Seniors and Drug Prices in Canada and the United States, 2008 Edition

   This is the Fraser Institute's third report comparing Canada-US price differences for the prescription drugs that are most important to Canadian seniors (aged 60 and older). This year's report analyzes prices for the drugs most commonly ...

5. The Misguided War Against Medicines 2008

   Government spending on all types of prescription drugs (patented and non-patented) is increasing faster than any other component of health spending. And new or patented medicines tend to be more expensive compared to older drugs and other health ...

6. Seniors and Drug Prices in Canada and the United States

   This paper compares Canada-US price differences for the drugs that were most important to Canadian seniors (aged 60 and older) in 2006. Prices are compared separately for brand name and generic prescription drugs. https://www.fraserinstitute.org/sites ...

7. The Misguided War Against Medicines 2007

   Government spending on all types of prescription drugs (patented and non-patented) is increasing faster than any other component of health spending. And new or patented medicines tend to be more expensive compared to older drugs and other health ...